1. Altman, D. G., Lausen, B., Sauerbrei, W. & Schumacher, M. (1994). Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829–835.
2. Barakat, R. R., Park, R. C., Grigsby, P. W., Muss, H. D. & Norris, H. (1997). Corpus: epithelial tumors. In Principles and Practice of Gynecologic Oncology, 2nd edn Hoskins WJ, Perez CA and Young RC (eds.), pp. 859–896, Lippincott-Raven: Philadelphia
3. Benraad, T. H. J., Geurts-Moespot, A., Sala, M., Piffanelli, A., Ross, A. & Foekens, J. A. (1992). Quality control of cathepsin D measurement by the EORTC Receptor Study Group. Eur J Cancer 28A: 72–75.
4. Capony, F., Garcia, J., Capdevielle, C., Rougeot, C., Ferrara, P. & Rochefort, H. (1986). Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human breast cancer cells. Eur J Biochem 161: 505–512.
5. Capony, F., Rougeot, C., Montcourrier, P., Cavailles, V., Salazar, G. & Rochefort, H. (1989). Increased secretion, altered processing, and glycosilation of procathepsin D in human mammary cancer cells. Cancer Res 46: 3904–3909.